🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT05466383
Recruiting Not applicable

Screening and Intervention for AIS in Haikou, Hainan Province, China

NCT05466383 · tracked via the Priya Life Science China tracker
Sponsor
Chaoyin Jiang
Phase
Not applicable
Started
2022-10-24
Last updated
2023-08-04

Condition(s) studied

AIS

Investigational drug(s) / intervention(s)

ExerciseBrace

Exercise: Exercise rehabilitation with Schroth method

Brace: Wear an orthopedic brace

Study summary

This is a single-center, prospective, non-randomized, open-label, interventional, real-world study. The mild/moderate AIS patients will be recruited through screening of 250,000 primary and secondary school students in Haikou, Hainan Province. The patients will be treated with different non-surgical interventions (exercise intervention or brace intervention) according to the physician's recommendations and the patient's intention. Patients will be followed up for 36 months to evaluate the effectiveness and safety of non-surgical interventions in the real world.

Eligibility

Sex
ALL
Min age
9 Years
Max age
16 Years
Healthy volunteers
No
Inclusion Criteria: 1. 9 years ≤ age ≤ 16 years 2. Diagnosis of AIS 3. 10°≤Cobb's angle\<45° 4. Signed informed consent form Exclusion Criteria: 1. With other developmental disorders, musculoskeletal disorders, nerve disorders, infection disorders, mental disorders, and other disorders 2. Obvious deformity of lower limbs and(or) feet 3. Previous or ongoing treatment of AIS 4. Difficulty to read, understanding, and complete the study questionnaires 5. Any criteria, which, in the opinion of the investigator, suggest that the subject would not be compliant with this study protocol

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Haikou orthopedic and diabetes hospital, Haikou orthopedic and diabetes hospital of Shanghai Sixth People's Hospital Haikou Hainan Recruiting

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05466383 on ClinicalTrials.gov ↗ ← All trials in China